DxI 600
Device
Beckman Coulter, Inc.
Total Payments
$833,319
Transactions
127
Doctors
29
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $833,319 | 127 | 29 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $798,261 | 81 | 95.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,780 | 5 | 3.3% |
| Travel and Lodging | $6,261 | 10 | 0.8% |
| Food and Beverage | $667.07 | 30 | 0.1% |
| Consulting Fee | $350.00 | 1 | 0.0% |
Payments by Type
Research
$798,261
81 transactions
General
$35,058
46 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Access AMH Assay as an aid in diagnosis | Beckman Coulter, Inc. | $281,247 | 0 |
| SAB Lab Testing | Beckman Coulter, Inc. | $178,429 | 0 |
| Access HCV assay testing | Beckman Coulter, Inc. | $91,828 | 0 |
| Access Assay as an aid in diagnosis | Beckman Coulter, Inc. | $91,028 | 0 |
| SAB start up and sample testing | Beckman Coulter, Inc. | $80,068 | 0 |
| Androgen feasibility studies | Beckman Coulter, Inc. | $65,415 | 0 |
| CHF Study | Beckman Coulter, Inc. | $9,035 | 0 |
| IRB Fee for SAB Pivotal | Beckman Coulter, Inc. | $1,200 | 0 |
Top Doctors Receiving Payments for DxI 600 — Page 2
Ad
Manufacturing Companies
- Beckman Coulter, Inc. $833,319
Product Information
- Type Device
- Total Payments $833,319
- Total Doctors 29
- Transactions 127
About DxI 600
DxI 600 is a device associated with $833,319 in payments to 29 healthcare providers, recorded across 127 transactions in the CMS Open Payments database. The primary manufacturer is Beckman Coulter, Inc..
Payment data is available from 2017 to 2017. In 2017, $833,319 was paid across 127 transactions to 29 doctors.
The most common payment nature for DxI 600 is "Unspecified" ($798,261, 95.8% of total).
DxI 600 is associated with 8 research studies, including "Access AMH Assay as an aid in diagnosis" ($281,247).